0001127602-23-018598.txt : 20230612
0001127602-23-018598.hdr.sgml : 20230612
20230612175219
ACCESSION NUMBER: 0001127602-23-018598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wright Christopher I
CENTRAL INDEX KEY: 0001838503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 231009558
MAIL ADDRESS:
STREET 1: C/O CYCLERION THERAPEUTICS, INC.
STREET 2: 245 FIRST STREET, 18TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-06-08
0001520262
Alkermes plc.
ALKS
0001838503
Wright Christopher I
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN
4 Ireland
1
0
Ordinary Shares
2023-06-08
4
M
0
373
A
373
D
Ordinary Shares
2023-06-08
4
F
0
90
31.54
D
283
D
Ordinary Shares
2023-06-08
4
M
0
3236
A
3519
D
Ordinary Shares
2023-06-08
4
F
0
777
31.54
D
2742
D
Restricted Stock Unit Award
2023-06-08
4
M
0
373
D
Ordinary Shares
373
0
D
Restricted Stock Unit Award
2023-06-08
4
M
0
3236
D
Ordinary Shares
3236
6473
D
Each restricted stock unit represents a contingent right to receive one ordinary share.
This award is fully vested in accordance with its terms.
Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 6/8/2023.
/s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
2023-06-12